ICU医疗 2026年季度报告

☒QUARTERLY REPORT PURSUANT TO SECTION13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March31, 2026or TRANSITION REPORT PURSUANT TO SECTION13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from:to Commission File No.:001-34634 (949) 366-2183(Registrant’s telephone number including area code)N/A(Former name, former address and former fiscal year, if changed since last report) Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant (1)has filed all reports required to be filed by Section13 or 15(d)of the Securities Exchange Act of 1934during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)has been subject to such filingrequirements for the past 90 days.YesNo Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule405 ofRegulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).YesNo Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or anemerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company"in Rule12b-2 of the Exchange Act. If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any newor revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: ICU MEDICAL, INC. AND SUBSIDIARIESForm 10-QMarch31, 2026Table of ContentsPageNumberForward Looking Statements1PART I.Financial InformationItem 1.Financial Statements (Unaudited)Condensed Consolidated Balance Sheets at March31, 2026 and December31, 20253Condensed Consolidated Statements of Operations for the Three Months Ended March31, 2026and 20254Condensed Consolidated Statements of Comprehensive Income for the Three Months EndedMarch31, 2026 and 20255Condensed Consolidated Statements of Stockholders' Equity for the Three Months EndedMarch31, 2026 and 20256Condensed Consolidated Statements of Cash Flows for the Three Months Ended March31,2026 and 20257Notes to Condensed Consolidated Financial Statements9Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations36Item 3.Quantitative and Qualitative Disclosures About Market Risk49Item 4.Controls and Procedures50PART II.Other InformationItem 1.Legal Proceedings51Item1A.Risk Factors51Item 2.Unregistered Sales of Equity Securities and Use of Proceeds51Item 5.Other Information51Item 6.Exhibits51Signature53 Forward-Looking Statements This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities LitigationReform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statementscontained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of1934, as amended (the “Exchange Act”). All statements, other than statements of historical fact, contained in this Quarterly Report on Form 10-Q, including, without limitation, statements regarding: our future results of operations and financial position, business strategy and approach;the anticipated benefits and costs associated with our purchase agreement with OPF (as defined below); expected capital expenditures;anticipated consumer demand; supply chain constraints; timing and resolution of the 2025 Warning Letter (as defined below); the expectedimpact of macroeconomic developments, such as foreign exchange, inflation and interest rates, and new accounting and tax regulations; tariffs;the impact of the One Big Beautiful Bill Act (the "OBBBA"); as well as plans and objectives of management for future operations, are forward-looking statements. Without limiting the foregoing, in some cases, you can identify forward-looking statements by terms such as “aim,” “may,”“will,” “should,” “expect,” “exploring,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,”“predict,” “potential,” “seeks,” or “continue” or the negative of these terms or other similar expressions, although not all forward-lookingstatements contain these words. No forward-looking statement is a guarantee of future results, performance, or achievements, and one shouldavoid placing undue reliance on such statements. The forward looking statements in this Quarterly Report on Form 10-Q are only predictions and are based largely on our currente